Device and method for modifying the shape of a body organ

Information

  • Patent Grant
  • 11311380
  • Patent Number
    11,311,380
  • Date Filed
    Tuesday, July 30, 2019
    5 years ago
  • Date Issued
    Tuesday, April 26, 2022
    2 years ago
Abstract
An intravascular support device includes a support or reshaper wire, a proximal anchor and a distal anchor. The support wire engages a vessel wall to change the shape of tissue adjacent the vessel in which the intravascular support is placed. The anchors and support wire are designed such that the vessel in which the support is placed remains open and can be accessed by other devices if necessary. The device provides a minimal metal surface area to blood flowing within the vessel to limit the creation of thrombosis. The anchors can be locked in place to secure the support within the vessel.
Description
INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are incorporated herein by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.


FIELD OF THE INVENTION

The present invention relates to medical devices in general, and in particular to devices for supporting internal body organs.


BACKGROUND OF THE INVENTION

The mitral valve is a portion of the heart that is located between the chambers of the left atrium and the left ventricle. When the left ventricle contracts to pump blood throughout the body, the mitral valve closes to prevent the blood being pumped back into the left atrium. In some patients, whether due to genetic malformation, disease or injury, the mitral valve fails to close properly causing a condition known as regurgitation, whereby blood is pumped into the atrium upon each contraction of the heart muscle. Regurgitation is a serious, often rapidly deteriorating, condition that reduces circulatory efficiency and must be corrected.


Two of the more common techniques for restoring the function of a damaged mitral valve are to surgically replace the valve with a mechanical valve or to suture a flexible ring around the valve to support it. Each of these procedures is highly invasive because access to the heart is obtained through an opening in the patient's chest. Patients with mitral valve regurgitation are often relatively frail thereby increasing the risks associated with such an operation.


One less invasive approach for aiding the closure of the mitral valve involves the placement of a support structure in the cardiac sinus and vessel that passes adjacent the mitral valve. The support structure is designed to push the vessel and surrounding tissue against the valve to aid its closure. This technique has the advantage over other methods of mitral valve repair because it can be performed percutaneously without opening the chest wall. While this technique appears promising, some proposed supports appear to limit the amount of blood that can flow through the coronary sinus and may contribute to the formation of thrombosis in the vessel. Therefore, there is a need for a tissue support structure that does not inhibit the flow of blood in the vessel in which it is placed and reduces the likelihood of thrombosis formation. Furthermore, the device should be flexible and securely anchored such that it moves with the body and can adapt to changes in the shape of the vessel over time.


The present invention is an intravascular support that is designed to change the shape of a body organ that is adjacent to a vessel in which the support is placed. In one embodiment of the invention, the support is designed to aid the closure of a mitral valve. The support is placed in a coronary sinus and vessel that are located adjacent the mitral valve and urges the vessel wall against the valve to aid its closure.


The intravascular support of the present invention includes a proximal and distal anchor and a support wire or reshaper disposed therebetween. The proximal and distal anchors circumferentially engage a vessel in which the support is placed. A support wire is urged against the vessel by the proximal and distal anchors to support the tissue adjacent the vessel.


In one embodiment of the invention, the proximal and distal supports are made from a wire hoop that presents a low metal coverage area to blood flowing within the vessel. The wire hoops may allow tissue to grow over the anchors to reduce the chance of thrombosis formation. The wire hoops have a figure eight configuration and can expand to maintain contact with the vessel walls if no vessel expands or changes shape.


In another embodiment of the invention, the proximal and distal anchors of the intravascular support are rotationally offset from each other. Locks on the support wire allow a physician to ensure that the anchors have been successfully deployed and prevent the support wire from collapsing within a vessel.





SUMMARY OF THE DISCLOSURE

The foregoing aspects and many of the attendant advantages of this invention will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein:



FIG. 1 illustrates an intravascular support for changing the shape of an internal body organ in accordance with one embodiment of the present invention;



FIG. 2 illustrates one method of deploying an intravascular support in accordance with the present invention;



FIG. 3 illustrates one embodiment of the intravascular support in accordance with the present invention;



FIG. 4 illustrates a distal anchor of the embodiment shown in FIG. 3;



FIG. 5 illustrates a proximal anchor of the embodiment shown in FIG. 3;



FIGS. 6A-6C are cross-sectional views of crimp tubes for use with one embodiment of the present invention;



FIG. 7 illustrates a proximal lock at the proximal end of the intravascular support as shown in FIG. 3;



FIG. 8 illustrates how the embodiment of the intravascular support shown in FIG. 3 is deployed from a catheter;



FIG. 9 illustrates an intravascular support in accordance with another embodiment of the present invention;



FIG. 10 illustrates a distal anchor of the intravascular support shown in FIG. 9;



FIG. 11 illustrates a proximal anchor of the intravascular support shown in FIG. 9;



FIG. 12 illustrates yet another embodiment of an intravascular support in accordance with the present invention;



FIG. 13 illustrates a distal anchor of the intravascular support shown in FIG. 12;



FIG. 14 illustrates a proximal anchor of the intravascular support shown in FIG. 12;



FIG. 15 illustrates an anchor and strut according to another embodiment of the invention;



FIG. 16 illustrates a double loop anchor according to another embodiment of the invention;



FIG. 17 illustrates a double loop anchor with a cross strut according to another embodiment of the invention; and



FIG. 18 illustrates an anchor with torsional springs according to another embodiment of the invention.





DETAILED DESCRIPTION

As indicated above, the present invention is a medical device that supports or changes the shape of tissue that is adjacent a vessel in which the device is placed. The present invention can be used in any location in the body where the tissue needing support is located near a vessel in which the device can be deployed. The present invention is particularly useful in supporting a mitral valve in an area adjacent a coronary sinus and vessel. Therefore, although the embodiments of the invention described are designed to support a mitral valve, those skilled in the art will appreciate that the invention is not limited to use in supporting a mitral valve.



FIG. 1 illustrates a mitral valve 20 having a number of flaps 22, 24 and 26 that should overlap and close when the ventricle of the heart contracts. As indicated above, some hearts may have a mitral valve that fails to close properly thereby creating one or more gaps 28 that allow blood to be pumped back into the left atrium each time the heart contracts. To add support to the mitral valve such that the valve completely closes, an intravascular support 50 is placed in a coronary sinus and vessel 60 that passes adjacent one side of the mitral valve 20. The intravascular support 50 has a proximal anchor 52, a distal anchor 54, and a support wire 56 or reshaper extending between the proximal and distal anchors. With the anchors 52 and 54 in place, the support wire 56 exerts a force through the coronary sinus wall on the postero-lateral mitral valve 20 thereby closing the one or more gaps 28 formed between the valve flaps. With the intravascular support 50 in place, the function of the mitral valve is improved.


As will be explained in further detail below, each of the proximal and distal anchors 52, 54 preferably circumferentially engages the wall of the vessel 60 in which it is placed. The support wire 56 is secured to a peripheral edge of the proximal and distal anchors such that the support wire is urged by the anchors against the vessel wall. Therefore, the support wire 56 and anchors 52, 54 present a minimal obstruction to blood flowing within the vessel.



FIG. 2 shows one possible method of delivering the intravascular support of the present invention to a desired location in a patient's body. An incision 80 is made in the patient's skin to access a blood vessel. A guide catheter 82 is advanced through the patient's vasculature until its distal end is positioned adjacent the desired location of the intravascular support. After positioning the guide catheter 82, a delivery catheter and advancing mechanism 84 are inserted through the guide catheter 82 to deploy the intravascular support at the desired location in the patient's body. Further detail regarding one suitable advancing mechanism 84 is described in commonly assigned U.S. patent application Ser. No. 10/313,914, filed Dec. 5, 2002, the disclosure of which is hereby incorporated by reference.



FIG. 3 illustrates one embodiment of an intravascular support in accordance with the present invention. The intravascular support 100 includes a support wire 102 having a proximal end 104 and a distal end 106. The support wire 102 is made of a biocompatible material such as stainless steel or a shape memory material such as nitinol wire.


In one embodiment of the invention, the support wire 102 comprises a double length of nitinol wire that has both ends positioned within a distal crimp tube 108. To form the support wire 102, the wire extends distally from the crimp tube 108 where it is bent to form a distal stop loop (see 121 in FIG. 4) having a diameter that is larger than the lumens within the distal crimp tube 108. After forming the distal stop loop, the wire returns proximally through the crimp tube 108 towards the proximal end of the support 100. Proximal to the proximal end of the crimp tube 108, is a distal lock 110 that is formed by the support wire bending away from the longitudinal axis of the support 102 and then being bent parallel to the longitudinal axis of the support before being bent again towards the longitudinal axis of the support. Therefore, the bends in the support wire form a half 110a of the distal lock that is used to secure the distal anchor in the manner described below. From the distal lock 110, the wire continues proximally through a proximal crimp tube 112. On exiting the proximal end of the proximal crimp tube 112, the wire is bent to form an arrowhead-shaped proximal lock 114. The wire of the support 102 then returns distally through the proximal crimp tube 112 to a position just proximal to the proximal end of the distal crimp tube 108 wherein the wire is bent to form a second half 110b of the distal lock 110.


Support wire 102 has a length that is selected based on its intended destination within a patient's vessel. For use in supporting a mitral valve, the support wire is preferably between one and six inches long and has a curved bend between its proximal end 104 and distal end 106 with a radius of curvature between 1 and 3 inches and most preferably with a radius of curvature of 1.8 inches. In addition, the wire used to form the support wire 102 is flexible enough to move with each heartbeat (thereby changing the force applied to the mitral valve annulus during the heartbeat) and stiff enough to support the mitral valve. In one embodiment, the wire used to form the support wire 102 is made of nitinol having a modulus of elasticity of 5-20×106 psi and a diameter of between 0.0110″ and 0.0150″ and most preferably 0.0140″. Other shape memory materials may be used for support wire as well.


At the distal end of the support wire 102 is a distal anchor 120 that is formed of a flexible wire such as nitinol or some other shape memory material. As is best shown in FIGS. 3 and 4, the wire forming the distal anchor has one end positioned within the distal crimp tube 108. After exiting the distal end of the crimp tube 108, the wire forms a figure eight configuration whereby it bends upward and radially outward from the longitudinal axis of the crimp tube 108. The wire then bends back proximally and crosses the longitudinal axis of the crimp tube 108 to form one leg of the figure eight. The wire is then bent to form a double loop eyelet or loop 122 around the longitudinal axis of the support wire 102 before extending radially outwards and distally back over the longitudinal axis of the crimp tube 108 to form the other leg of the figure eight. Finally, the wire is bent proximally into the distal end of the crimp tube 108 to complete the distal anchor 120.


The distal anchor is expanded by sliding the double eyelet 122 of the distal anchor from a position that is proximal to the distal lock 110 on the support wire to a position that is distal to the distal lock 110. The bent-out portions 110a and 110b of support wire 110 are spaced wider than the width of double eyelet 122 and provide camming surfaces for the locking action. Distal movement of eyelet 122 pushes these camming surfaces inward to permit eyelet 122 to pass distally of the lock 110, then return to their original spacing to keep eyelet 122 in the locked position.


The dimensions of the distal anchor are selected so that the diameter of the distal anchor in a plane perpendicular to the axis of the lumen in which the anchor is deployed is preferably between 100% and 300%, most preferably between 130% and 200%, of the diameter of the lumen prior to deployment. When treating mitral valve regurgitation by placement of the device in the coronary sinus, the diameter of the coronary sinus may expand over time after deployment. Oversizing the anchor combined with the inherent deformability and recoverability properties of the anchor material (particularly nitinol or some other shape memory material) enables the anchor to continue to expand from its initial deployment size as the lumen distends and expands over time.


Upon expansion, the distal anchor circumferentially engages the vessel wall with a radially outwardly directed force that is distributed unequally around the circumference of the anchor by distending the vessel wall in variable amounts along the axial length of the anchor. The unequal distribution of force helps the anchor contact the lumen wall securely by creating bumps and ridges that are not parallel to the central axis of the lumen. In its expanded configuration the distal anchor's diameter is at least 50%-500% and most preferably 100%-300% of the anchor's diameter in the unexpanded configuration. The open cross-sectional area of the lumen through the anchor is at least 50% and most preferably 80%-100% of the lumen cross sectional area prior to redeployment of the anchor.


In addition, the metal coverage of the anchor, as defined by the percentage of the lumen surface area through which the anchor extends that is exposed to a metal surface, is between 5% and 30% and most preferably 10%. The wire used to form the distal anchor 120 is preferably nitinol having a diameter of between 0.0110″ and 0.0150″ and most preferably 0.0140 inches. Other shape memory materials may be used as well.


During insertion, a physician can tactilely feel when the eyelet 122 has been slid over the distal lock 110 in order to determine when the distal anchor has been set within a vessel lumen. In addition, if the anchor is misplaced, it can be collapsed by pulling the eyelet 122 proximally over the distal lock 110 and repositioning the anchor in the unexpanded configuration. The force required to capture the distal anchor is preferably less than 20 lbs. and more preferably less than 10 lbs.



FIG. 4 also illustrates how the crimp tube 108 is held in place between the distal lock 110 on the proximal side and the stop loop 121 at the distal end of the support wire 102. The wires of the distal anchor 120 exit the distal end of the crimp tube 108 at an angle of approximately 45 degrees before looping back over the length of the distal crimp tube 108. Therefore, the distal end of the anchor is relatively atraumatic to avoid damage to a vessel during placement.


At the proximal end of the intravascular support is a proximal anchor 140 that is preferably formed of a biocompatible, elastic wire such as stainless steel or a shape memory material such as nitinol. As is best shown in FIGS. 3 and 5, the proximal anchor 140 in one embodiment is made of a single length of wire having a first end positioned within a proximal crimp tube 112. The wire extends distally from the crimp tube 112 and bends radially outward and away from the longitudinal axis of the crimp tube 112 before being bent proximally and crossing the longitudinal axis of the crimp tube 112 in order to form a first leg of a figure eight configuration. The wire then is bent to form a double eyelet or loop 142 around the longitudinal axis of the support wire 102 wherein the eyelet 142 has a diameter that allows it to be forced over the proximal lock 114. After forming the eyelet 142, the wire extends outwardly and away from the longitudinal axis of the crimp tube 112 before being bent distally over and across the longitudinal axis of the crimp tube 112 to form the second leg of a figure eight. Finally, the wire is bent proximally and extends into the distal end of the crimp tube 112.


Like the distal anchor, the proximal anchor is expanded and locked by sliding the double eyelet 142 of the proximal anchor from a position that is proximal to the proximal lock 114 on the support wire to a position that is distal to the proximal lock 114. As can be seen in FIG. 7, the proximal lock 114 has an “arrowhead” shape whereby the proximal end of the lock is bent away from the longitudinal axis of the support wire at an angle that is less steep than the distal end of the proximal lock. The less steep section makes it easier to advance the eyelet 142 over the lock in the distal direction than to retrieve the eyelet 142 over the proximal lock 114 in the proximal direction. Distal movement of eyelet 142 cams the less steep proximal surfaces inward to permit eyelet 142 to pass distally of the lock 114, then return to their original spacing to keep eyelet 142 in the locked position.


As can be seen by comparing the proximal anchor 140 with the distal anchor 120 in FIG. 3, the proximal anchor has a larger radius of curvature because it is designed to fit within a larger diameter portion of the coronary sinus. The dimensions of the proximal anchor are selected so that the diameter of the proximal anchor in a plane perpendicular to the axis of the lumen in which the anchor is deployed is preferably between 100% and 300%, most preferably between 130% and 200%, of the diameter of the lumen prior to deployment. As with the distal anchor, oversizing the proximal anchor combined with the inherent deformability and recoverability properties of the anchor material (particularly nitinol or some other shape memory material) enables the anchor to continue to expand from its initial deployment size as the lumen distends and expands over time.


Upon expansion, the proximal anchor circumferentially engages the vessel wall with a radially outwardly directed force that is distributed unequally around the circumference of the anchor by distending the vessel wall in variable amounts along the axial length of the anchor. As with the distal anchor, the unequal distribution of force helps the proximal anchor contact the lumen wall securely by creating bumps and ridges that are not parallel to the central axis of the lumen. In its expanded configuration the proximal anchor's diameter is at least 50%-500% and most preferably 100%-300% of the anchor's diameter in the unexpanded configuration. The open cross-sectional area of the lumen through the anchor is at least 50% and most preferably 80%-100% of the lumen cross sectional area prior to redeployment of the anchor.


In one embodiment of the invention, the proximal and distal anchors are oriented such that the planes of the anchors are offset with respect to each other by an angle of approximately 30 degrees. The offset helps the intravascular support 100 seat itself in the coronary sinus and vessel surrounding the mitral valve in certain mammals. However, it will be appreciated that if the support is designed for other uses, the proximal and distal anchors may be offset by more or less depending upon the anatomy of the intended destination.



FIGS. 6A-6C illustrate cross-sectional views of the crimp tubes in which the wires that form the support wire 102 and proximal and distal anchors 120, 140 are threaded. In one embodiment, the crimp tubes comprise a biocompatible material such as titanium having a number of holes extending longitudinally through the tube through which the wires are threaded. In FIG. 6A, a tube 150 has four holes 152, 154, 156, 158 positioned in approximately a square configuration within the circumference of the tube 150. As shown in FIG. 6B, a tube 160 includes four holes 162, 164, 166, 168 therein that are positioned in a diamond configuration. FIG. 6C shows another tube 170 having four holes 172, 174, 176, 178. Here the holes 172, 174 lie in a first plane and the second pair of holes 176, 178 lie in a second plane that is offset from the plane of the holes 172, 174. By changing the orientation of the holes 176, 178 with respect to the holes 172, 174, the relative plane of wires passing through the holes can be adjusted. Thus in the example shown in FIG. 3, the proximal anchor may be formed with a crimp tube such as that shown in FIG. 6A or FIG. 6B while the distal anchor may be formed in a crimp tube such as that shown in FIG. 6C in order to adjust the angular orientation between the proximal anchor and the distal anchor. In an alternative embodiment, the crimp tubes at the proximal and distal ends of the support wire 102 are the same and the angular offset between the proximal and distal anchor is achieved by bending the wires at the desired angle. Although the crimp tubes shown use one hole for each wire passing through the crimp tube, it will be appreciated that other configurations may be provided such as slots or other passages for the wires to pass through.


In another embodiment, the distal and proximal anchors are attached to the support wire by a wire, such as nitinol wire or other shape memory material. The attaching wire may be spiral wrapped around the base of each anchor and around the support wire. In another embodiment, each anchor may be attached to the support wire by wrapping the anchor wire around the support wire. In yet another embodiment, the two anchors and the support wire may be made from a single wire, such as nitinol wire or other shape memory material.



FIG. 8 illustrates one method for delivering an intravascular support 100 in accordance with the present invention to a desired location in the body. As indicated above, intravascular support 100 is preferably loaded into and routed to a desired location within a catheter 200 with the proximal and distal anchors in a collapsed or deformed condition. That is, the eyelet 122 of the distal anchor 120 is positioned proximally of the distal lock 110 and the eyelet 142 of the proximal anchor 140 is positioned proximal to the proximal lock 114. The physician ejects the distal end of the intravascular support from the catheter 200 into the lumen by advancing the intravascular support or retracting the catheter or a combination thereof. A pusher (not shown) provides distal movement of the intravascular support with respect to catheter 200, and a tether 201 provides proximal movement of the intravascular support with respect to catheter 200. Because of the inherent recoverability of the material from which it is formed, the distal anchor begins to expand as soon as it is outside the catheter. Once the intravascular support is properly positioned, the eyelet 122 of the distal anchor is pushed distally over the distal lock 110 so that the distal anchor 120 further expands and locks in place to securely engage the lumen wall and remains in the expanded condition. Next, the proximal end of the support wire 102 is tensioned by applying a proximally-directed force on the support wire and distal anchor to apply sufficient pressure on the tissue adjacent the support wire to modify the shape of that tissue. In the case of the mitral valve, fluoroscopy, ultrasound or other imaging technology may be used to see when the support wire supplies sufficient pressure on the mitral valve to aid in its complete closure with each ventricular contraction without otherwise adversely affecting the patient. A preferred method of assessing efficacy and safety during a mitral valve procedure is disclosed in copending U.S. patent application Ser. No. 10/366,585, filed Feb. 12, 2003, and titled “Method of Implanting a Mitral Valve Therapy Device,” the disclosure of which is incorporated herein by reference. Once the proper pressure of the support wire has been determined, the proximal anchor is deployed from the catheter and allowed to begin its expansion. The eyelet 142 of the proximal anchor 140 is advanced distally over the proximal lock 114 to expand and lock the proximal anchor, thereby securely engaging the lumen wall and maintaining the pressure of the support wire against the lumen wall. Finally, the mechanism for securing the proximal end of the intravascular support can be released. In one embodiment, the securement is made with a braided loop 202 at the end of tether 201 and a hitch pin 204. The hitch pin 204 is withdrawn thereby releasing the loop 202 so it can be pulled through the proximal lock 114 at the proximal end of the intravascular support 100.


In many contexts, it is important for the device to occupy as little of the lumen as possible. For example, when using the device and method of this invention to treat mitral valve regurgitation, the device should be as open as possible to blood flow in the coronary sinus (and to the introduction of other medical devices, such as pacing leads) while still providing the support necessary to reshape the mitral valve annulus through the coronary sinus wall. The combination of the device's open design and the use of nitinol or some other shape memory material enables the invention to meet these goals. When deployed in the coronary sinus or other lumen, the device preferably occupies between about 1.5% and about 5.5% of the overall volume of the section of lumen in which it is deployed.


In many embodiments of the invention, the use of a shape memory material such as nitinol is particularly important. The percentage of shape memory material by volume in the device is preferably between about 30% and 100%, most preferably between about 40% and 60%.


In some instances it may be necessary to move or remove an intravascular support after deployment by recapturing the device into a catheter. Prior to deployment of the proximal anchor, the distal anchor may be recaptured into the delivery catheter by simultaneously holding the device in place with tether 201 while advancing catheter distally over distal anchor 120 so that the entire device is once again inside catheter 200. The distally directed force of the catheter collapses distal anchor 120 into a size small enough to fit into catheter 200 again. Likewise, after deployment of both anchors but prior to releasing the securement mechanism as described above, the intravascular support may be recaptured into the delivery catheter by simultaneously holding the device in place with tether 201 while advancing catheter distally first over proximal anchor 140, over support wire 102, and finally over distal anchor 120. The distally directed forced of catheter 200 collapses anchors 120 and 140 into a size small enough to fit into catheter 200 again. If the securement mechanism has been detached from the device prior to recapture, the device still may be recaptured into the delivery catheter or another catheter by grasping the proximal end of the device with a grasper or tether and by advancing the catheter distally over the device.


In one embodiment of the invention, proximal anchor 140 includes a recapture guidance and compression element. In the embodiment shown in FIG. 5, the slope of the two proximal arms 143 and 144 of proximal anchor 140 is small in proximal portions 145 and 146 of the arms, then increases in more distal portions 147 and 148 of the arms. This shape guides the catheter to move distally over the anchor more easily and to help compress the anchor to a collapsed shape as the catheter advances during recapture.


Likewise, the two proximal arms 123 and 124 of distal anchor 120 have a shallower slope in their proximal portions 145 and 146 and an increased slope in more distal portions 147 and 148. While recapture of the distal anchor is somewhat easier due to its smaller size compared to the proximal anchor, this recapture guidance and compression feature enhances the ease with which recapture is performed.



FIG. 9 illustrates an alternative embodiment of the intravascular support of the present invention. In this embodiment, an intravascular support 250 has a support wire 252 and a distal anchor 254 and a proximal anchor 256. In the embodiment shown in FIG. 9, the distal anchor 254 is made from the same wire used to form the support wire 252. As best shown in FIG. 10, the wire used to form the support wire 252 extends distally through a distal crimp tube 260 before looping radially outward and returning proximally and across the longitudinal axis of the crimp tube 260 to form one leg of a figure eight. The wire then winds around the axis of the suspension wire 252 to form an eyelet 262. The wire then continues radially outward and distally across the longitudinal axis of the crimp tube 260 to form the second leg of a figure eight. After forming the figure eight, the wire enters the distal end of the crimp tube 260 in the proximal direction to form the other half of the support wire 252. A distal lock 264 is formed proximal to the distal crimp tube 260 by outwardly extending bends in the wires that form the support wire 252. The distal lock 264 prevents the double eyelet 262 from sliding proximally and collapsing the distal anchor 254 when positioned in a vessel.


As shown in FIG. 11, a distal anchor 256 is constructed in a fashion similar to the proximal anchor 140 shown in FIG. 3. That is, the proximal anchor 256 is formed of a separate wire than the wire used to form the support wire 252 and distal anchor 254. The wire of the proximal anchor has one end within a proximal crimp tube 270. The wire extends distally out of the end of the crimp tube and bends radially outward before returning back and across the longitudinal axis of the crimp tube 270. At the proximal end of the crimp tube 270, the wire of the proximal anchor forms a double eyelet 272 around the longitudinal axis of the support wire 252. The wire then continues radially outward and distally over the longitudinal axis of the crimp tube 270 to form the second leg of the figure eight whereupon it is bent proximally into the distal end of the crimp tube 270.



FIG. 12 shows yet another embodiment of an intravascular support in accordance with the present invention. Here, an intravascular support 300 comprises a support wire 302, a distal anchor 304 and a proximal anchor 306. As in the embodiment shown in FIG. 9, the distal anchor 304 and the support wire 302 are formed of the same wire. To form the distal anchor, the wire extends distally through a distal crimp tube 310 and exits out the distal end before extending radially outward and bending back and across the longitudinal axis of the crimp tube 310 to form one leg of a figure eight. The loop then forms an eyelet 312 around the longitudinal axis of the support wire 302 before bending radially outward and distally across the longitudinal axis of the crimp tube 310 to form a second leg of the figure eight. The wire then enters the distal end of the crimp tube 310 in the proximal direction. The support wire 302 may have one or two outwardly extending sections that form a distal stop 314 to maintain the position of the eyelet 312 once the distal anchor is set in the expanded configuration.


The proximal anchor 306 is formed from a separate wire as shown in FIG. 14. The wire has one end positioned within the proximal crimp tube 320 that extends distally outward and radially away from the longitudinal axis of the crimp tube 320 before being bent proximally and across the longitudinal axis of the crimp tube 320 to form one leg of the figure eight. The wire then winds around the longitudinal axis of the support wire to form an eyelet 322 before being bent distally and across the longitudinal axis of the crimp tube 320 to enter the distal end of the crimp tube 320 in the proximal direction. As will be appreciated, the proximal crimp tube 320 of the embodiment shown in FIG. 12 holds four wires wherein the distal crimp tube 310 need only hold two wires.



FIGS. 15-18 show other embodiments of the invention. In the embodiment shown in FIG. 15, the intravascular support has an anchor 400 formed as a loop 404 emerging from a window 406 in a crimp tube 408. Extending from one end 411 of crimp tube 408 is a support strut 410 which connects with loop 404. Also extending from the crimp tube 408 is a support wire 412. Loop 404 and support 410 may be formed from nitinol, stainless steel, or any other appropriate material. The intravascular support includes another anchor. The intravascular support of this embodiment may be delivered and deployed in the manner discussed above with respect to the embodiment described above.



FIG. 16 shows another embodiment of an anchor 450 for an intravascular support. Anchor 450 is formed from two loops 452 and 454 emerging from a window 456 and an end 457 of a crimp tube 458. A support wire 462 also extends from the crimp tube. Loops 452 and 454 may be formed from nitinol, stainless steel, or any other appropriate material. The intravascular support includes another anchor. The intravascular support of this embodiment may be delivered and deployed in the manner discussed above with respect to the embodiment described above.



FIG. 17 shows yet another embodiment of an anchor 500 for an intravascular support according to this invention. Anchor 500 is formed from two loops 502 and 504 emerging from a window 506 and an end 507 of a crimp tube 508. A cross strut 505 connects the loops. A support wire 512 also extends from the crimp tube. Loops 502 and 504 and strut 505 may be formed from nitinol, stainless steel, or any other appropriate material. The intravascular support includes another anchor. The intravascular support of this embodiment may be delivered and deployed in the manner discussed above with respect to the embodiment described above.



FIG. 18 is a modification of the embodiment shown in FIGS. 3-7. In this embodiment, torsional springs 558 of proximal anchor 550 have been formed as single loops or eyelets in the anchor's wire 552. These springs make the anchor 550 more compliant by absorbing some of the force applied to the anchor during locking. While FIG. 18 shows a proximal anchor with two springs 558, any number of springs could be used on either the proximal or the distal anchor.


While the preferred embodiment of the invention has been illustrated and described, it will be appreciated that various changes can be made therein without departing from the scope of the invention. Therefore, the scope of the invention is to be determined from the following claims and equivalents thereto.

Claims
  • 1. A method of modifying the geometry of a mitral valve, comprising: delivering a tissue shaping device to a coronary sinus;deploying a distal anchor from a delivery device and into the coronary sinus to allow the expandable distal anchor to expand;locking the distal anchor in a locked configuration;applying a proximal cinching force to the distal anchor to reshape tissue;while maintaining the proximal cinching force, deploying the proximal anchor from the delivery device to allow the proximal anchor to expand; andlocking the proximal anchor in a locked configuration after allowing the proximal anchor to expand,wherein locking the proximal anchor comprises locking the proximal anchor in a locked configuration in which the proximal anchor extends, relative to a connector extending between the distal and proximal anchors, further radially outward than the distal anchor when the distal anchor is in the locked configuration.
  • 2. The method of claim 1, wherein locking the proximal anchor in a locked configuration comprises moving a first lock element relative to a second lock element until the first lock element is in a locked position relative to the second lock element.
  • 3. The method of claim 2, wherein moving a first lock element comprises moving a first lock element distally relative to the second lock element.
  • 4. The method of claim 1, wherein applying a proximal cinching force does not cause a change in length of a connector extending between the distal anchor and the proximal anchor.
  • 5. The method of claim 1, wherein allowing the distal anchor to expand comprises allowing a distal region of the distal anchor to expand radially outward and allowing a proximal region of the distal anchor to expand radially outward.
  • 6. The method of claim 1, wherein allowing the proximal anchor to expand comprises allowing a distal region of the proximal end to expand radially outward and allowing a proximal region of the proximal anchor to expand radially outward.
  • 7. A method of modifying the geometry of a mitral valve, comprising: delivering a tissue shaping device to a coronary sinus;deploying a distal anchor from a delivery device and into the coronary sinus to allow the expandable distal anchor to expand;locking the distal anchor in a locked configuration;applying a proximal cinching force to the distal anchor to reshape tissue; andwhile maintaining the proximal cinching force, deploying the proximal anchor from the delivery device to allow the proximal anchor to expand,wherein locking the distal anchor in a locked configuration comprises moving a first lock element relative to a second lock element until the first lock element is in a locked position relative to the second lock element.
  • 8. The method of claim 7, wherein moving a first lock element comprises moving a first lock element distally relative to the second lock element.
  • 9. The method of claim 7, further comprising locking the proximal anchor in a locked configuration, wherein locking the proximal anchor in a locked configuration comprises moving a proximal first lock element relative to a proximal second lock element until the proximal first lock element is in a locked position relative to the proximal second lock element.
  • 10. The method of claim 9, wherein moving a proximal first lock element comprises moving a proximal first lock element distally relative to the proximal second lock element.
  • 11. The method of claim 7, wherein applying a proximal cinching force does not cause a change in length of a connector extending between the distal anchor and the proximal anchor.
  • 12. The method of claim 7, wherein allowing the distal anchor to expand comprises allowing a distal region of the distal anchor to expand radially outward and allowing a proximal region of the distal anchor to expand radially outward.
  • 13. The method of claim 7, wherein allowing the proximal anchor to expand comprises allowing a distal region of the proximal end to expand radially outward and allowing a proximal region of the proximal anchor to expand radially outward.
  • 14. The method of claim 7, further comprising locking the proximal anchor in a locked configuration, wherein locking the proximal anchor comprises locking the proximal anchor in a locked configuration in which the proximal anchor extends, relative to a connector extending between the distal and proximal anchors, further radially outward than the distal anchor when the distal anchor is in the locked configuration.
  • 15. A method of modifying the geometry of a mitral valve, comprising: delivering a tissue shaping device to a coronary sinus;deploying a distal anchor from a delivery device and into the coronary sinus to allow the expandable distal anchor to expand;locking the distal anchor in a locked configuration;applying a proximal cinching force to the distal anchor to reshape tissue; andwhile maintaining the proximal cinching force, deploying the proximal anchor from the delivery device to allow the proximal anchor to expand,wherein deploying the proximal anchor from the delivery device to allow the proximal anchor to expand causes the proximal anchor to be rotationally offset from the distal anchor, relative to a connector extending between the distal and proximal anchors.
  • 16. The method of claim 15, further comprising locking the proximal anchor in a locked configuration, wherein locking the proximal anchor in a locked configuration comprises moving a proximal first lock element relative to a proximal second lock element until the proximal first lock element is in a locked position relative to the proximal second lock element.
  • 17. The method of claim 15, further comprising locking the proximal anchor in a locked configuration, wherein locking the proximal anchor comprises locking the proximal anchor in a locked configuration in which the proximal anchor extends, relative to a connector extending between the distal and proximal anchors, further radially outward than the distal anchor when the distal anchor is in the locked configuration.
  • 18. The method of claim 15, wherein applying a proximal cinching force does not cause a change in length of a connector extending between the distal anchor and the proximal anchor.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 11/782,527, filed Jul. 24, 2007, which is a divisional of U.S. application Ser. No. 10/429,172, filed May 2, 2003, now abandoned, entitled “Device and Method for Modifying the Shape of a Body Organ,” each of which is herein incorporated by reference in its entirety.

US Referenced Citations (304)
Number Name Date Kind
3620212 Fannon, Jr. et al. Nov 1971 A
3786806 Johnson et al. Jan 1974 A
3890977 Wilson Jun 1975 A
3974526 Dardik et al. Aug 1976 A
3995623 Blake et al. Dec 1976 A
4055861 Carpentier et al. Nov 1977 A
4164046 Cooley Aug 1979 A
4485816 Krumme Dec 1984 A
4550870 Krumme et al. Nov 1985 A
4588395 Lemelson May 1986 A
4830023 de Toledo et al. May 1989 A
5061277 Carpentier et al. Oct 1991 A
5099838 Bardy Mar 1992 A
5104404 Wolff Apr 1992 A
5197978 Hess Mar 1993 A
5250071 Palermo Oct 1993 A
5261916 Engelson Nov 1993 A
5265601 Mehra Nov 1993 A
5344426 Lau et al. Sep 1994 A
5350420 Cosgrove et al. Sep 1994 A
5411549 Peters May 1995 A
5433727 Sideris Jul 1995 A
5441515 Khosravi et al. Aug 1995 A
5449373 Pinchasik et al. Sep 1995 A
5454365 Bonutti Oct 1995 A
5458615 Klemm et al. Oct 1995 A
5474557 Mai Dec 1995 A
5507295 Skidmore Apr 1996 A
5507802 Imran Apr 1996 A
5514161 Limousin May 1996 A
5554177 Kieval et al. Sep 1996 A
5562698 Parker Oct 1996 A
5575818 Pinchuk Nov 1996 A
5584867 Limousin et al. Dec 1996 A
5601600 Ton Feb 1997 A
5617854 Munsif Apr 1997 A
5662703 Yurek et al. Sep 1997 A
5676671 Inoue Oct 1997 A
5733325 Robinson et al. Mar 1998 A
5733328 Fordenbacher Mar 1998 A
5741297 Simon Apr 1998 A
5752969 Cunci et al. May 1998 A
5800519 Sandock Sep 1998 A
5824071 Nelson et al. Oct 1998 A
5836882 Frazin Nov 1998 A
5871501 Leschinsky et al. Feb 1999 A
5891193 Robinson et al. Apr 1999 A
5895391 Farnholtz Apr 1999 A
5899882 Waksman et al. May 1999 A
5908404 Elliot Jun 1999 A
5928258 Khan et al. Jul 1999 A
5935161 Robinson et al. Aug 1999 A
5954761 Machek et al. Sep 1999 A
5961545 Lentz et al. Oct 1999 A
5978705 KenKnight et al. Nov 1999 A
5984944 Forber Nov 1999 A
6001118 Daniel et al. Dec 1999 A
6007519 Rosselli Dec 1999 A
6015402 Sahota Jan 2000 A
6022371 Killion Feb 2000 A
6027517 Crocker et al. Feb 2000 A
6045497 Schweich, Jr. et al. Apr 2000 A
6053900 Brown et al. Apr 2000 A
6056775 Borghi et al. May 2000 A
6077295 Limon et al. Jun 2000 A
6077297 Robinson et al. Jun 2000 A
6080182 Shaw et al. Jun 2000 A
6086611 Duffy et al. Jul 2000 A
6096064 Routh Aug 2000 A
6099549 Bosma et al. Aug 2000 A
6099552 Adams Aug 2000 A
6129755 Mathis et al. Oct 2000 A
6159220 Gobron et al. Dec 2000 A
6162168 Schweich, Jr. et al. Dec 2000 A
6171320 Monassevitch Jan 2001 B1
6183512 Howanec et al. Feb 2001 B1
6190406 Duerig et al. Feb 2001 B1
6200336 Pavcnik et al. Mar 2001 B1
6210432 Solem et al. Apr 2001 B1
6228098 Kayan et al. May 2001 B1
6241757 An et al. Jun 2001 B1
6254628 Wallace et al. Jul 2001 B1
6267783 Letendre et al. Jul 2001 B1
6275730 KenKnight et al. Aug 2001 B1
6306141 Jervis Oct 2001 B1
6312446 Huebsch et al. Nov 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6342067 Mathis et al. Jan 2002 B1
6345198 Mouchawar et al. Feb 2002 B1
6352553 van der Burg et al. Mar 2002 B1
6352561 Leopold et al. Mar 2002 B1
6358195 Green et al. Mar 2002 B1
6368345 Dehdashtian et al. Apr 2002 B1
6395017 Dwyer et al. May 2002 B1
6402781 Langberg et al. Jun 2002 B1
6409750 Hyodoh et al. Jun 2002 B1
6419696 Ortiz et al. Jul 2002 B1
6442427 Bouts et al. Aug 2002 B1
6464720 Boatman et al. Oct 2002 B2
6478776 Rosenman et al. Nov 2002 B1
6503271 Duerig et al. Jan 2003 B2
6537314 Langberg et al. Mar 2003 B2
6556873 Smits Apr 2003 B1
6562066 Martin May 2003 B1
6562067 Mathis May 2003 B2
6569198 Wilson et al. May 2003 B1
6589208 Ewers et al. Jul 2003 B2
6599314 Mathis et al. Jul 2003 B2
6602288 Cosgrove et al. Aug 2003 B1
6602289 Colvin et al. Aug 2003 B1
6623521 Steinke et al. Sep 2003 B2
6626899 Houser et al. Sep 2003 B2
6629534 St. Goar et al. Oct 2003 B1
6629994 Gomez et al. Oct 2003 B2
6643546 Mathis et al. Nov 2003 B2
6648881 KenKnight et al. Nov 2003 B2
6652538 Kayan et al. Nov 2003 B2
6652571 White et al. Nov 2003 B1
6656221 Taylor et al. Dec 2003 B2
6676702 Mathis Jan 2004 B2
6689164 Seguin Feb 2004 B1
6709425 Gambale et al. Mar 2004 B2
6716158 Raman et al. Apr 2004 B2
6718985 Hlavka et al. Apr 2004 B2
6721598 Helland et al. Apr 2004 B1
6723038 Schroeder et al. Apr 2004 B1
6733521 Chobotov et al. May 2004 B2
6743219 Dwyer et al. Jun 2004 B1
6764510 Vidlund et al. Jul 2004 B2
6773446 Dwyer et al. Aug 2004 B1
6776784 Ginn Aug 2004 B2
6790231 Liddicoat et al. Sep 2004 B2
6793673 Kowalsky et al. Sep 2004 B2
6797001 Mathis et al. Sep 2004 B2
6798231 Iwasaki et al. Sep 2004 B2
6800090 Alferness et al. Oct 2004 B2
6805128 Pless et al. Oct 2004 B1
6810882 Langberg et al. Nov 2004 B2
6821297 Snyders Nov 2004 B2
6824562 Mathis et al. Nov 2004 B2
6827690 Bardy Dec 2004 B2
6881220 Edwin et al. Apr 2005 B2
6890353 Cohn et al. May 2005 B2
6899734 Castro et al. May 2005 B2
6908478 Alferness et al. Jun 2005 B2
6908482 McCarthy et al. Jun 2005 B2
6926690 Renati Aug 2005 B2
6935404 Duerig et al. Aug 2005 B2
6949122 Adams et al. Sep 2005 B2
6955689 Ryan et al. Oct 2005 B2
6960229 Mathis et al. Nov 2005 B2
6964683 Kowalsky et al. Nov 2005 B2
6966926 Mathis Nov 2005 B2
6976995 Mathis et al. Dec 2005 B2
7004958 Adams et al. Feb 2006 B2
7087064 Hyde Aug 2006 B1
7128073 van der Burg et al. Oct 2006 B1
7152605 Khairkhahan et al. Dec 2006 B2
7175653 Gaber Feb 2007 B2
7179282 Alferness et al. Feb 2007 B2
7270676 Alferness et al. Sep 2007 B2
7309354 Mathis et al. Dec 2007 B2
7311729 Mathis et al. Dec 2007 B2
7316708 Gordon et al. Jan 2008 B2
7364588 Mathis et al. Apr 2008 B2
7452375 Mathis et al. Nov 2008 B2
7503931 Kowalsky et al. Mar 2009 B2
7591826 Alferness et al. Sep 2009 B2
7608102 Adams et al. Oct 2009 B2
7635387 Reuter et al. Dec 2009 B2
7674287 Alferness et al. Mar 2010 B2
7758639 Mathis Jul 2010 B2
7814635 Gordon Oct 2010 B2
7828841 Mathis et al. Nov 2010 B2
7828842 Nieminen et al. Nov 2010 B2
7828843 Alferness et al. Nov 2010 B2
7837728 Nieminen et al. Nov 2010 B2
7837729 Gordon et al. Nov 2010 B2
7887582 Mathis et al. Feb 2011 B2
8006594 Hayner et al. Aug 2011 B2
8062358 Mathis et al. Nov 2011 B2
8075608 Gordon et al. Dec 2011 B2
8172898 Alferness et al. May 2012 B2
8182529 Gordon et al. May 2012 B2
8250960 Hayner et al. Aug 2012 B2
8439971 Reuter et al. May 2013 B2
8974525 Nieminen et al. Mar 2015 B2
9320600 Nieminen et al. Apr 2016 B2
9408695 Mathis et al. Aug 2016 B2
9474608 Mathis et al. Oct 2016 B2
9526616 Nieminen et al. Dec 2016 B2
9597186 Nieminen et al. Mar 2017 B2
9827098 Mathis et al. Nov 2017 B2
9827099 Mathis et al. Nov 2017 B2
9827100 Mathis et al. Nov 2017 B2
9956076 Mathis et al. May 2018 B2
9956077 Nieminen et al. May 2018 B2
10052205 Mathis et al. Aug 2018 B2
10166102 Nieminen et al. Jan 2019 B2
10327900 Mathis et al. Jun 2019 B2
10449048 Nieminen et al. Oct 2019 B2
10456257 Mathis et al. Oct 2019 B2
10456259 Mathis et al. Oct 2019 B2
11033257 Nieminen Jun 2021 B2
11109971 Nieminen et al. Sep 2021 B2
20010018611 Solem et al. Aug 2001 A1
20010041899 Foster Nov 2001 A1
20010044568 Langberg et al. Nov 2001 A1
20010049558 Liddicoat et al. Dec 2001 A1
20020010507 Ehr et al. Jan 2002 A1
20020016628 Langberg et al. Feb 2002 A1
20020042621 Liddicoat et al. Apr 2002 A1
20020042651 Liddicoat et al. Apr 2002 A1
20020049468 Streeter et al. Apr 2002 A1
20020055774 Liddicoat May 2002 A1
20020065554 Streeter May 2002 A1
20020095167 Liddicoat et al. Jul 2002 A1
20020138044 Streeter et al. Sep 2002 A1
20020151961 Lashinski et al. Oct 2002 A1
20020156526 Hlavka et al. Oct 2002 A1
20020161377 Rabkin et al. Oct 2002 A1
20020161393 Demond et al. Oct 2002 A1
20020183837 Streeter et al. Dec 2002 A1
20020183838 Liddicoat et al. Dec 2002 A1
20020183841 Cohn et al. Dec 2002 A1
20020188170 Santamore et al. Dec 2002 A1
20020193827 McGuckin et al. Dec 2002 A1
20030018358 Saadat Jan 2003 A1
20030040771 Hyodoh et al. Feb 2003 A1
20030069636 Solem et al. Apr 2003 A1
20030078465 Pai et al. Apr 2003 A1
20030078654 Taylor et al. Apr 2003 A1
20030083613 Schaer May 2003 A1
20030088305 Van Schie et al. May 2003 A1
20030093148 Bolling et al. May 2003 A1
20030130730 Cohn et al. Jul 2003 A1
20030135267 Solem et al. Jul 2003 A1
20040019377 Taylor et al. Jan 2004 A1
20040039443 Solem et al. Feb 2004 A1
20040073302 Rourke et al. Apr 2004 A1
20040098116 Callas et al. May 2004 A1
20040102839 Cohn et al. May 2004 A1
20040102840 Solem et al. May 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040133220 Lashinski et al. Jul 2004 A1
20040133240 Adams et al. Jul 2004 A1
20040133273 Cox Jul 2004 A1
20040138744 Lashinski et al. Jul 2004 A1
20040148019 Vidlund et al. Jul 2004 A1
20040148020 Vidlund et al. Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040153147 Mathis Aug 2004 A1
20040158321 Reuter et al. Aug 2004 A1
20040172046 Hlavka et al. Sep 2004 A1
20040176840 Langberg Sep 2004 A1
20040193191 Starksen et al. Sep 2004 A1
20040193260 Alferness et al. Sep 2004 A1
20040220654 Mathis et al. Nov 2004 A1
20040220657 Nieminen et al. Nov 2004 A1
20040260342 Vargas et al. Dec 2004 A1
20050004667 Swinford et al. Jan 2005 A1
20050027351 Reuter et al. Feb 2005 A1
20050033419 Alferness et al. Feb 2005 A1
20050038506 Webler Feb 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050096740 Langberg et al. May 2005 A1
20050107810 Morales et al. May 2005 A1
20050137449 Nieminen et al. Jun 2005 A1
20050137450 Aronson et al. Jun 2005 A1
20050137451 Gordon et al. Jun 2005 A1
20050149182 Alferness et al. Jul 2005 A1
20050197692 Pai et al. Sep 2005 A1
20050197693 Pai et al. Sep 2005 A1
20050197694 Pai et al. Sep 2005 A1
20050209690 Mathis et al. Sep 2005 A1
20050216077 Mathis et al. Sep 2005 A1
20050261704 Mathis Nov 2005 A1
20050272969 Alferness et al. Dec 2005 A1
20060030882 Adams et al. Feb 2006 A1
20060041305 Lauterjung Feb 2006 A1
20060116758 Swinford et al. Jun 2006 A1
20060142854 Alferness et al. Jun 2006 A1
20060161169 Nieminen et al. Jul 2006 A1
20060167544 Nieminen et al. Jul 2006 A1
20060271174 Nieminen et al. Nov 2006 A1
20070066879 Mathis et al. Mar 2007 A1
20070239270 Mathis et al. Oct 2007 A1
20080015407 Mathis et al. Jan 2008 A1
20080015679 Mathis et al. Jan 2008 A1
20080015680 Mathis et al. Jan 2008 A1
20100280602 Mathis Nov 2010 A1
20110066234 Gordon et al. Mar 2011 A1
20110106117 Mathis et al. May 2011 A1
20120123532 Mathis May 2012 A1
20120197389 Alferness et al. Aug 2012 A1
20170189185 Nieminen et al. Jul 2017 A1
20180256330 Wypych Sep 2018 A1
20190262136 Nieminen et al. Aug 2019 A1
20190365537 Wypych Dec 2019 A1
20200008943 Mathis et al. Jan 2020 A1
20200253732 Nieminen et al. Aug 2020 A1
20210298732 Nieminen et al. Sep 2021 A1
20210330460 Mathis et al. Oct 2021 A1
20210393403 Nieminen et al. Dec 2021 A1
Foreign Referenced Citations (46)
Number Date Country
0893133 Jan 1999 EP
0903110 Mar 1999 EP
0968688 Jan 2000 EP
1050274 Nov 2000 EP
1095634 May 2001 EP
1177779 Feb 2002 EP
2181670 May 2010 EP
0741604 Dec 1955 GB
2754067 Mar 1998 JP
2000-308652 Nov 2000 JP
2001-503291 Mar 2001 JP
2003-503101 Jan 2003 JP
2003-521310 Jul 2003 JP
9902455 Dec 2000 SE
WO9856435 Dec 1998 WO
WO0044313 Aug 2000 WO
WO0060995 Oct 2000 WO
WO0074603 Dec 2000 WO
WO0100111 Jan 2001 WO
WO0119292 Mar 2001 WO
WO0150985 Jul 2001 WO
WO0154618 Aug 2001 WO
WO0187180 Nov 2001 WO
WO0200099 Jan 2002 WO
WO0201999 Jan 2002 WO
WO0205888 Jan 2002 WO
WO0219951 Mar 2002 WO
WO0234118 May 2002 WO
WO0247539 Jun 2002 WO
WO02053206 Jul 2002 WO
WO02060352 Aug 2002 WO
WO02062263 Aug 2002 WO
WO02062270 Aug 2002 WO
WO02062408 Aug 2002 WO
WO02076284 Oct 2002 WO
WO02078576 Oct 2002 WO
WO02096275 Dec 2002 WO
WO03015611 Feb 2003 WO
WO03037171 May 2003 WO
WO03049647 Jun 2003 WO
WO03049648 Jun 2003 WO
WO03055417 Jul 2003 WO
WO03059198 Jul 2003 WO
WO03063735 Aug 2003 WO
WO2004045463 Jun 2004 WO
WO2004084746 Oct 2004 WO
Non-Patent Literature Citations (9)
Entry
El-Maasarany et al.; The coronary sinus conduit function: Anatomical study (relationship to adjacent structures); http://europace.oxfordjournals.org/cge/content/full/7/5/475. (accessed Sep. 9, 2008).
Gray, H. Anatomy of the Human Body. The Systemic Veins. Philadelphia: Lea & Febiger, 1918; Bartleby.com. 2000. Available at www.bartleby.com/107/. Accessed Jun. 7, 2006.
Heartsite.com. Echocardiogram, 1999; p. 1-4. A.S.M. Systems Inc. Available at: http://www.heartsite.com/html/echocardiogram.html. Accessed Jul. 1, 2005.
Papageorgiou, P., et al. Coronary Sinus Pacing Prevents Induction of Atrial Fibrillation. Circulation. Sep. 16, 1997; 96(6): 1893-1898.
Pelton et al. Medical uses of nitinol; Material Science Forum; vols. 327-328; pp. 63-70; 2000 (held in Kanazawa, Japan, May 1999).
Pijls et al.; Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses; The New England J. of Med.; vol. 334; No. 26; pp. 1703-1708; Jun. 27, 1996.
Pai, Suresh; U.S. Appl. No. 60/329,694 entitled “Percutaneous cardiac support structures and deployment means,” filed Oct. 16, 2001.
Yamanouchi, et al.; Activation Mapping from the coronary sinus may be limited by anatomic variations; vol. 21 pp. 2522-2526; Nov. 1998.
Mathis et al.; U.S. Appl. No. 16/450,686 entitled “Tissue shaping device,” filed Jun. 24, 2019.
Related Publications (1)
Number Date Country
20190350708 A1 Nov 2019 US
Divisions (1)
Number Date Country
Parent 10429172 May 2003 US
Child 11782527 US
Continuations (1)
Number Date Country
Parent 11782527 Jul 2007 US
Child 16526843 US